Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 350 $ 28
Prepaid expenses 483 246
Total current assets 833 274
Deposits 12 12
Operating lease right-to-use asset 72 110
Total other assets 84 122
Total assets 917 396
Current Liabilities:    
Accounts payable 2,171 1,940
Accrued expenses 1,228 2,379
Accrued interest 4,182 2,029
Operating lease liability 82 120
Line of credit 31 31
Convertible notes 23,000 13,207
Total current liabilities 30,694 19,706
Total liabilities 30,694 19,706
Stockholders' Deficit:    
Common stock - $0.001 par value; 750,000,000 shares authorized; and 77,518,614 and 69,784,699 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 78 70
Additional paid-in capital 550,984 548,096
Accumulated deficit (580,695) (567,332)
Noncontrolling interest (169) (169)
Total stockholders' deficit (29,777) (19,310)
Total liabilities and stockholders' deficit 917 396
Series C    
Stockholders' Deficit:    
Convertible preferred stock 1 1
Series J-1    
Stockholders' Deficit:    
Convertible preferred stock $ 24 $ 24